Menu

Education onlyLivozo does not offer this treatment. This page explains the topic. There is no intake, purchase or prescription path.

CJC-1295: what the research peptide is, what FDA has flagged and why Livozo does not sell it.

CJC-1295 is a lab-made, long-acting relative of growth hormone-releasing hormone. It is often sold online as a "research use only" peptide. This page is education only. Livozo does not sell research-use-only peptides.

  • Education only
  • Research peptide
  • Not offered

FDA status. CJC-1295 is not an FDA-approved drug. FDA lists it among bulk substances that may present significant safety risks when used in compounding.

01

What it is.

CJC-1295 was designed to last longer in the body than natural GHRH. In a small 2006 study in healthy adults, one injection raised growth hormone levels for 6 days or more and IGF-1 levels for 9 to 11 days.[1]

FDA has placed CJC-1295 on its list of bulk drug substances that may present significant safety risks in compounding. FDA says compounded drugs containing it may pose a risk of immune reactions for certain routes.[2]

02

What clinicians consider.

A licensed clinician looks at your full picture before deciding anything. These are the kinds of questions they ask. They are not a diagnosis.

  • Why you are interested in growth hormone-related peptides
  • Whether symptoms point to a condition that needs proper testing
  • Any peptide or hormone you have already used, and where it came from
  • Your history of cancer, diabetes, or pituitary conditions
03

What the evidence says.

CJC-1295 is not an FDA-approved drug. FDA lists it among bulk substances that may present significant safety risks when used in compounding.

The 2006 study measured hormone levels over 28 to 49 days. It did not test health outcomes such as strength, body composition or aging.[1]

Limits. Human data on CJC-1295 are limited to small, short studies of hormone levels. There is no good evidence for claims about muscle, fat loss or anti-aging, and products sold as "research use only" are not tested for use in people.

04

Risks and when to get help.

FDA flags a risk of immune reactions with compounded CJC-1295 for certain routes of administration.[2]

Research-use-only vials are not made or checked as medicines. Their contents, strength and sterility are unknown.

Tell a clinician if

  • Tell a clinician about any peptide you have injected, and where you got it.
  • Tell a clinician if you have cancer or a history of cancer.
  • Tell a clinician if you have diabetes or a pituitary condition.

Get urgent care if

  • Swelling of the face, lips, tongue or throat, or trouble breathing
  • Fever, spreading redness, warmth or pus at an injection site
  • Chest pain or a racing, irregular heartbeat
05

What this page covers.

  • What CJC-1295 is and what the research measured
  • Why FDA has flagged it for compounding
  • The risks of research-use-only peptides
  • Why Livozo does not sell research-use-only peptides

What Livozo does not do

  • Livozo does not sell, prescribe or ship CJC-1295 or other CJC-class peptides.
  • Livozo has no intake, checkout or clinician referral for CJC-1295 or other CJC-class peptides.
  • Livozo does not diagnose or give personal medical advice on this page.
  • Livozo does not sell research-use-only products.
06

Cost.

Price not yet available. Livozo does not sell CJC-1295 and has no price for it.

Questions to ask any provider

  • Livozo does not offer CJC-1295, so there is no Livozo price.
  • If another provider quotes a price, ask whether the product is FDA-approved or compounded.
  • Ask which licensed pharmacy makes it and whether it is made for injection or for skin.
  • Products sold online as "research use only" are not medicines for people, at any price.
07

Availability.

Education only. Livozo does not offer CJC-1295 or other CJC-class peptides. There is no intake, purchase or prescription path for it on this site, now or at launch. Livozo does not sell research-use-only peptides.

Review and sources.

Written by
Livozo Editorial
Medical review
TODO(clinical) Reviewer pending. See review status
Published
Last updated
Next review
Set at clinical sign-off
  1. Teichman SL et al. Prolonged stimulation of GH and IGF-I secretion by CJC-1295 in healthy adults. J Clin Endocrinol Metab. 2006
  2. FDA — Certain bulk drug substances for use in compounding that may present significant safety risks

Questions about CJC.

Is CJC-1295 FDA-approved?
No. FDA lists it among bulk substances that may present significant safety risks in compounding.
Is it the same as sermorelin?
No. Both relate to growth hormone-releasing hormone, but CJC-1295 is a different, longer-acting molecule with far less human data.
Are research-use-only peptides legal to use?
They are sold with labels saying they are not for human use. Their contents and sterility are not checked as medicines.
Can I get CJC-1295 from Livozo?
No. Livozo does not sell research-use-only peptides, and there is no intake, purchase or prescription path for CJC-1295.

Keep reading.